Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial

Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-04-30T14:21:15.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant revisions, including updates to the study design and randomization details for the dociparstat sodium trial related to COVID-19. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    32%
    Check dated 2025-04-16T10:28:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.6%
    Check dated 2025-04-09T05:12:40.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:25:12.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-11T04:00:26.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:23:01.000Z thumbnail image

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.